Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-17T17:18:18.074Z Has data issue: false hasContentIssue false

Chlorpromazine and Pecazine in Chronic Schizophrenia

Published online by Cambridge University Press:  08 February 2018

Lindsay Hurst*
Affiliation:
Shenley Hospital, Hertfordshire
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

In this paper the effect of chlorpromazine is compared with that of pecazinet on the schizophrenic population of three chronic psychiatric wards.

Delay, Deniker and Harl (1952) introduced chlorpromazine into psychiatry. Pecazine was first used by Kline and Jacob (1955) and Hiob and Hippius (1955). Thorpe and Baker (1956), in a double-blind, controlled trial, found that both drugs reduced tension significantly in deteriorated, female, schizophrenic patients. Baker and Thorpe (1957) found that pecazine did not significantly reduce daytime incontinence in deteriorated psychotic patients. The trial was controlled and blind. Jones (unpublished), in a double-blind, controlled trial on disturbed psychotic patients, found chlorpromazine to be effective but could find no evidence that pecazine had any effect.

Information

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1960 
Submit a response

eLetters

No eLetters have been published for this article.